SPRC
SciSparc Ltd.
NASDAQ · Healthcare · Biotechnology · IL
$4.51
+1.35%Margins
Gross margin
46.4%
EBITDA margin
-994.7%
EBIT margin
-1022.1%
Net margin
-1422.8%
FCF margin
-483.3%
-287.3%
Return on equity
-159.8%
Return on assets
-190.0%
Return on invested capital
0.13x
Asset turnover
-$4.1M
Cash from operations
$7.90
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Dec 1, 2025